Skip to main content
Terug
Watch Compare

Evolus, Inc.

Datakwaliteit: 100%
EOLS
Nasdaq Manufacturing Chemicals
€ 4,27
▲ € 0,03 (0,71%)
Marktkapitalisatie: 272,93 M
Prijs
€ 4,20
Marktkapitalisatie
272,93 M
Dagbereik
—
52-Weeksbereik
—
Volume
—
Openen —
50D / 200D Gem.
—
50D / 200D Gem.
—

Quick Summary

Belangrijkste Punten

Revenue grew 31,40% annually over 5 years — strong growth
Negative free cash flow of -45,71 M
Revenue growth is decelerating — 1Y growth trails 5Y average by 19,79%
Capital efficient — spends only 1,16% of revenue on capex

Groei

Revenue Growth (5Y)
31,40%
Boven sectorgemiddelde (1,82%)
Revenue (1Y)11,61%
Earnings (1Y)N/A
FCF Growth (3Y)N/A

Kwaliteit

Return on Equity
N/A
ROIC-16,26%
Net Margin-17,38%
Op. Margin-10,99%

Veiligheid

Debt / Equity
N/A
Current Ratio2,02
Interest Coverage-1,66

Waardering

PE (TTM|2027)
-5,29 | 17,50
Onder sectorgemiddelde (-1,48)
P/B RatioN/A
EV/EBITDAN/A
Dividend YieldN/A

Koershistorie

Financiële Trends

Sectorvergelijking

vs Manufacturing sector mediaan (1366 peers)
Metriek Aandeel Sector Mediaan
P/E -5,3 -1,5
P/B — 1,6
ROE % — -53,5
Net Margin % -17,4 -41,5
Rev Growth 5Y % 31,4 1,8
D/E — 0,3

Koersdoel Analisten

6 analisten
Buy
Huidig
€ 4,27
+243.5%
Koersdoel
€ 14,67
€ 10,00
€ 14,00
€ 20,00
Vooruitzicht
Forward K/W 17,79
Forward WPA € 0,24
Omzet Sch. 388,17 M

Winstschattingen

Periode WPA Sch. Omzet Sch. Analisten
FY2027 € 0,24
€ 0,14 – € 0,33
 388,17 M 5
FY2026 -€ 0,12
-€ 0,21 – -€ 0,04
 330,01 M 5

Winstverassingen

Laatste 4 kwartalen
Kwartaal Geschat WPA Werkelijk WPA Verrassing
Q42025 € 0,04 € 0,01 -64,8%
Q32025 -€ 0,18 -€ 0,15 +19,4%
Q22025 -€ 0,09 -€ 0,26 -175,1%
Q12025 -€ 0,14 -€ 0,17 -18,6%

ETFs Holding This Stock

PILL logo PILL Direxion Daily Pharmaceutical & Medical Bull 3X ETF
0,62% weight
MXMTX MXMTX
0,13% weight
IJSTX IJSTX
0,13% weight
IJSAX IJSAX
0,13% weight
IJSSX IJSSX
0,13% weight
VPRSX VPRSX
0,13% weight
IJSIX IJSIX
0,13% weight
GSSC logo GSSC Goldman Sachs ActiveBeta U.S. Small Cap Equity ETF
0,10% weight
QWVOX QWVOX
0,09% weight
AFSM logo AFSM First Trust Active Factor Small Cap ETF
0,06% weight

All Fundamental Metrics
Growth
Revenue Growth (1Y) 11,61% Revenue Growth (3Y) 21,27%
Earnings Growth (1Y) N/A Earnings Growth (3Y) N/A
Revenue Growth (5Y) 31,40% Earnings Growth (5Y) N/A
Profitability
Revenue (TTM) 297,18 M Net Income (TTM) -51,64 M
ROE N/A ROA -23,06%
Gross Margin 66,33% Operating Margin -10,99%
Net Margin -17,38% Free Cash Flow (TTM) -45,71 M
ROIC -16,26% FCF Growth (3Y) N/A
Safety
Debt / Equity N/A Current Ratio 2,02
Interest Coverage -1,66 Asset Turnover 1,33
Working Capital 68,18 M Tangible Book Value -98,69 M
Dividends
Dividend Yield N/A Payout Ratio N/A
Dividend Growth (3Y) N/A Dividend Growth (5Y) N/A
Consecutive Div Years N/A
Valuation
P/E Ratio -5,29 Forward P/E N/A
P/B Ratio N/A P/S Ratio 0,92
PEG Ratio N/A Forward PEG N/A
EV/EBITDA N/A Fwd EV/EBITDA N/A
Forward P/S N/A Fwd Earnings Yield N/A
FCF Yield -16,75%
Market Cap 272,93 M Enterprise Value 375,18 M
Per Share
EPS (Diluted TTM) -0,80 Revenue / Share 4,57
FCF / Share -0,70 OCF / Share -0,65
EPS CAGR (1Y) N/A EPS CAGR (5Y) N/A
EPS CAGR (10Y) N/A
Efficiency
CapEx / Revenue 1,16% FCF Conversion 88,51%
SBC-Adj. FCF -66,48 M Growth Momentum -19,79

Income Statement

Annual, most recent first
Metric FY2025 FY2024 FY2023 FY2022 FY2021
Revenue 297,18 M 266,27 M 202,09 M 148,62 M 99,67 M
Net Income -51,64 M -50,42 M -61,69 M -74,41 M -46,81 M
EPS (Diluted) -0,80 -0,81 -1,08 -1,33 -0,94
Gross Profit 197,11 M 182,30 M — — —
Operating Income -32,66 M -34,41 M -49,23 M -65,33 M -44,41 M
EBITDA — — — — —
R&D Expenses — — — — 2,06 M
SG&A Expenses 220,79 M 198,03 M 164,94 M 141,84 M 112,07 M
D&A 7,51 M 5,30 M 5,13 M 3,72 M 5,62 M
Interest Expense 19,69 M 18,74 M 13,83 M 9,10 M —
Income Tax 677.000,0 664.000,0 176.000,0 95.000,0 42.000,0

Balance Sheet

Annual, most recent first
Metric FY2025 FY2024 FY2023 FY2022 FY2021
Total Assets 225,87 M 232,57 M 189,00 M 177,98 M 257,48 M
Total Liabilities 248,97 M 227,05 M 209,69 M 159,48 M 175,61 M
Shareholders' Equity -23,11 M 5,52 M -20,69 M 18,50 M 81,88 M
Total Debt 146,10 M 121,51 M 120,36 M 71,88 M 71,22 M
Cash & Equivalents 53,83 M 86,95 M 62,84 M 53,92 M 146,26 M
Current Assets 142,92 M 151,34 M 112,42 M 100,80 M 178,80 M
Current Liabilities 75,31 M 62,96 M 48,29 M 46,51 M 57,66 M